This Week in Neurology: Stroke Recovery and Treatment Strategies

This week's research offers varied insights into optimizing outcomes for patients with stroke and other neurological conditions. From the New England Journal of Medicine, a trial examined triple-pill therapy for patients with prior intracerebral hemorrhage ^[2].

The study enrolled 1670 patients with baseline systolic blood pressure between 130 and 160 mm Hg. Treatment with a combination of telmisartan, amlodipine, and indapamide significantly reduced recurrent stroke compared to placebo over a median follow-up of 2.5 years, though clinicians are advised to monitor for discontinuation due to adverse events.

Meanwhile, attention turned to rehabilitation strategies for stroke survivors with lower-limb dysfunction. A systematic review and Bayesian network meta-analysis published in the American journal of physical medicine & rehabilitation evaluated various approaches using data from 2448 patients ^[1].

The analysis indicated that resistance training combined with electrical stimulation therapy yielded the greatest improvements in balance and lower-limb motor function. Conversely, combining resistance training with stretching training showed the best enhancement of walking ability, supporting the use of individualized strategies for recovery.

Elsewhere this week, researchers in the Journal of Korean medical science conducted a prospective, randomized, multicenter trial comparing first-line suction aspiration against a combination technique for acute cerebral infarction ^[3].

The trial enrolled 1136 patients amenable to both methods to evaluate successful recanalization and good clinical outcome at 90 days. However, specific numerical results for primary and secondary outcomes were not reported in the provided data, limiting definitive clinical conclusions regarding the superiority of one technique over the other.

We also saw research in the New England Journal of Medicine regarding mental health support for multiple sclerosis patients ^[4].

A systematic review and meta-analysis evaluated cognitive behavioral therapy for depressive symptoms across 22 studies. Significant improvements were observed starting from the second month and persisted for up to 6 months post-intervention. The authors note that delivery modality can be flexible, though specific adverse events and p-values were not reported. Finally, a meta-analysis in Neurology modeled the cost-effectiveness of intravenous alteplase plus thrombectomy versus thrombectomy alone for large vessel occlusion stroke using data from 2,268 patients ^[5].

The findings suggest that cost-effectiveness depends heavily on onset-to-IVT time, with benefits diminishing after 170 minutes and becoming detrimental after 200 minutes.